Bristol Myers Squibb Stocks List

Recent Signals

Date Stock Signal Type
2021-05-11 BMY Cup with Handle Other
2021-05-11 BMY 20 DMA Resistance Bearish
2021-05-11 CNCE New 52 Week Low Weakness
2021-05-11 CTMX 50 DMA Resistance Bearish
2021-05-11 RAPT Spinning Top Other
2021-05-11 RAPT Stochastic Reached Oversold Weakness
2021-05-11 RAPT Gilligan's Island Buy Setup Bullish Swing Setup
2021-05-11 SNY 20 DMA Support Bullish

Recent News for Bristol Myers Squibb Stocks

Date Stock Title
May 11 SNY Sanofi and Cellectis partner for alemtuzumab in CAR T-cells trials
May 11 SNY Cellectis and Sanofi partner on alemtuzumab as lymphodepletion agent for allogeneic CAR-T
May 11 SNY Sanofi is alleged to have deleted Emails linked to Zantac recall
May 11 RAPT RAPT Therapeutics EPS misses by $0.04, beats on revenue
May 11 RAPT RAPT Therapeutics Reports First Quarter 2021 Financial Results
May 10 SNY FDA Outlines Plan For Restarting Facility Inspections Halted Due To Pandemic
May 10 SNY COVID-19 is not at the point yet where we can have mass gatherings: Doctor
May 9 CTMX CytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q1 2021 Results - Earnings Call Transcript
May 9 BMY Pfizer Or Bristol-Myers Squibb: Which Is A Better Buy?
May 8 CTMX CytomX Therapeutics, Inc. (CTMX) Q1 2021 Earnings Call Transcript
May 8 SNY These four COVID-19 vaccines could soon join the pandemic fight
May 8 SNY Could AstraZeneca and Sanofi Win Big in RSV?
May 7 SNY ‘We are not out of the woods with this pandemic’: Doctor
May 7 SNY Pfizer begins process of seeking full U.S. vaccine approval: RPT
May 6 CTMX CytomX Therapeutics (CTMX) Reports Q1 Loss, Misses Revenue Estimates
May 6 CTMX CytomX EPS beats by $0.06, misses on revenue
May 6 CTMX CytomX Therapeutics Announces First Quarter 2021 Financial Results and Provides Business Update
May 6 CTMX CytomX Therapeutics, Inc. to Host Earnings Call
May 6 RAPT RAPT THERAPTICS (RAPT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
May 6 SNY U.S. backing waiver of patent protection for vaccines is a ‘complex issue’: Doctor

Bristol-Myers Squibb Company (BMS) is an American pharmaceutical company, headquartered in New York City.
Bristol-Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.
BMS' primary R&D sites are located in Lawrence, New Jersey (formerly Squibb, near Princeton) and Wallingford, Connecticut (formerly Bristol-Myers); with other sites in East Syracuse, New York; Princeton Pike, Hopewell Township and New Brunswick, New Jersey; and in Swords, Ireland; Braine-l'Alleud, Belgium; Tokyo, Japan; and Bangalore, India.

More about Bristol Myers Squibb
Browse All Tags